Department of Radiation Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, People's Republic of China.
School of Nuclear Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
PLoS One. 2022 Dec 1;17(12):e0278422. doi: 10.1371/journal.pone.0278422. eCollection 2022.
The positional accuracy of multi-leaf collimators (MLC) is important in stereotactic body radiotherapy (SBRT). The aim of this study was to investigate the impact between MLC positional error and dosimetry of volume intensity modulated (VMAT) and general intensity modulated (IMRT) plans for non-small cell lung cancer (NSCLC). Fifteen patients with NSCLC were selected to design the 360 SBRT-VMAT plans and the 360 SBRT-IMRT error plans. The DICOM files for these treatment plans were imported into a proprietary computer program that introduced delivery errors. Random and systematic MLC position (0.1, 0.2, 0.5, 1.0, 1.5, and 2.0 mm) errors were introduced. The systematic errors were shift errors (caused by gravity), opening errors, and closing errors. The CI, GI, d2cm and generalized equivalent uniform dose (gEUD) were calculated for the original plan and all treatment plans, accounting for the errors. Dose sensitivity was calculated using linear regression for MLC position errors. The random MLC errors were relatively insignificant. MLC shift, opening, and closing errors had a significant effect on the dose distribution of the SBRT plan. VMAT was more significant than IMRT. To ensure that the gEUD variation of PTV is controlled within 2%, the shift error, opening error, and closing error of IMRT should be less than 2.4 mm, 1.15 mm, and 0.97 mm, respectively. For VMAT, the shift error, opening error, and closing error should be less than 0.95 mm, 0.32 mm, and 0.38 mm, respectively. The dose sensitivity results obtained in this study can be used as a guide for patient-based quality assurance efforts. The position error of the MLC system had a significant impact on the gEUD of the SBRT technology. The MLC systematic error has a greater dosimetric impact on the VMAT plan than on the IMRT plan for SBRT, which should be carefully monitored.
多叶准直器(MLC)的位置精度在立体定向体放射治疗(SBRT)中非常重要。本研究旨在探讨非小细胞肺癌(NSCLC)容积调强弧形(VMAT)和常规调强(IMRT)计划中 MLC 位置误差与剂量学之间的关系。选择 15 例 NSCLC 患者设计 360°SBRT-VMAT 计划和 360°SBRT-IMRT 误差计划。将这些治疗计划的 DICOM 文件导入专有的计算机程序中,以引入传输误差。引入随机和系统的 MLC 位置(0.1、0.2、0.5、1.0、1.5 和 2.0mm)误差。系统误差包括重力引起的移位误差、开启误差和关闭误差。计算原始计划和所有考虑误差的治疗计划的 CI、GI、d2cm 和广义等效均匀剂量(gEUD)。使用线性回归计算 MLC 位置误差对剂量的敏感性。随机 MLC 误差相对较小。MLC 移位、开启和关闭误差对 SBRT 计划的剂量分布有显著影响。VMAT 比 IMRT 更显著。为了确保 PTV 的 gEUD 变化控制在 2%以内,IMRT 的移位误差、开启误差和关闭误差应分别小于 2.4mm、1.15mm 和 0.97mm。对于 VMAT,移位误差、开启误差和关闭误差应分别小于 0.95mm、0.32mm 和 0.38mm。本研究中的剂量敏感性结果可作为患者质量保证工作的指南。MLC 系统的位置误差对 SBRT 技术的 gEUD 有显著影响。MLC 系统误差对 SBRT 的 VMAT 计划的剂量学影响大于 IMRT 计划,应仔细监测。